Aqua Bio Technology ASA (DE:3FZ) has released an update.
Aqua Bio Tech ASA has issued new shares for acquisition settlements with Ovalen AS and Varming Holding AS, involving over 5.9 million shares at varying subscription prices. The transactions are part of the company’s strategy to expand its biotech and natural skincare portfolio, and ABT is listed on the Euronext Expand market.
For further insights into DE:3FZ stock, check out TipRanks’ Stock Analysis page.
